Stimcell Energetics (STME) EBIT Growth (3y) (2019 - 2024)
Stimcell Energetics (STME) EBIT Growth (3y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 13.06% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 13.22% |
| Feb 29, 2024 | 30.21% |
| Nov 30, 2023 | 38.33% |
| Aug 31, 2023 | 36.00% |
| May 31, 2023 | 35.91% |
| Feb 28, 2023 | 25.33% |
| Nov 30, 2022 | 23.91% |
| Aug 31, 2022 | 15.26% |
| May 31, 2022 | 49.59% |
| Feb 28, 2022 | -38.80% |
| Nov 30, 2021 | -49.86% |
| Aug 31, 2021 | -43.79% |
| May 31, 2020 | 16.83% |
| Feb 29, 2020 | 4.71% |
| Nov 30, 2019 | -7.44% |
| Aug 31, 2019 | 2.50% |
| May 31, 2019 | -56.12% |
| Feb 28, 2019 | 37.19% |